Impact on Waitlist Outcomes from Changes in the Medical Eligibility of Candidates for Simultaneous Liver-Kidney Transplantation Following Implementation of the 2017 Organ Procurement and Transplantation Network/United Network for Organ Sharing Policy in the United States

Shingo Shimada; Toshihiro Kitajima; Yukiko Suzuki; Yasutaka Kuno; Tayseer Shamaa; Tommy Ivanics; Kelly Collins; Michael Rizzari; Atsushi Yoshida; Marwan Abouljoud; Dilip Moonka; Shunji Nagai

doi:10.12659/AOT.934850

18 February 2022 : Original article

Impact on Waitlist Outcomes from Changes in the Medical Eligibility of Candidates for Simultaneous Liver-Kidney Transplantation Following Implementation of the 2017 Organ Procurement and Transplantation Network/United Network for Organ Sharing Policy in the United States

Shingo Shimada^1ADEF*, Toshihiro Kitajima^1BCE, Yukiko Suzuki^1BD, Yasutaka Kuno^1BD, Tayseer Shamaa^1BC, Tommy Ivanics

^1BCE, Kelly Collins^1DE, Michael Rizzari^1BD, Atsushi Yoshida^1BD, Marwan Abouljoud^1BD, Dilip Moonka^2BD, Shunji Nagai^1ACE

DOI: 10.12659/AOT.934850

Ann Transplant 2022; 27:e934850

Authors information Article notes Copyright and License information

Background Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Figure 1 Figure explains the selection criteria of the study cohort. A total of 4641 of the 5320 patients who were listed for simultaneous liver-kidney transplant (SLK) between January 2015 and March 2019 were eligible for this study. Patients were divided into 2 groups: before the 2017 policy (n=2975), and after the 2017 policy (n=1666).

Back to the Article

Impact on Waitlist Outcomes from Changes in the Medical Eligibility of Candidates for Simultaneous Liver-Kidney Transplantation Following Implementation of the 2017 Organ Procurement and Transplantation Network/United Network for Organ Sharing Policy in the United States

Your Privacy